Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06335589 · ClinicalTrials.gov registry record · NA
Adapting Treatment Delivery to Improve Retention in Evidence-Based PTSD Treatment
A NA study of Stress Disorders, Post-Traumatic, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT06335589: Completed NA study of Stress Disorders, Post-Traumatic, sponsored by VA Office of Research and Development.
NCT06335589 is a NA study of Stress Disorders, Post-Traumatic that has completed, run by VA Office of Research and Development. The registered enrollment target is 30 participants, below the 156-participant average among 66 other Stress Disorders, Post-Traumatic trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06335589, a NA study of Stress Disorders, Post-Traumatic, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
Posttraumatic stress disorder (PTSD) is prevalent among Veterans and effective evidence-based psychotherapies (EBPs) for PTSD have been implemented within the Veterans Health Administration (VHA). However, retention in PTSD EBPs is poor. Premature dropout is associated with worse clinical outcomes and greater healthcare utilization. Delivery of PTSD EBPs in a massed format, typically three or more days per week delivered within a month, have shown promise for increasing retention. The present study is a pilot feasibility and acceptability study comparing massed PTSD treatment to treatment as usual (e.g., typically weekly treatment).
Primary Outcome
Proportion of Veterans who complete a full course of an assigned PTSD treatment
Conditions Studied
Interventions
- OTHER EBP-Massed
- OTHER EBP-TAU
Study Locations (1)
North Carolina
- Durham VA Medical Center, Durham, NC - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2024-06-24 |
| Est. Completion | 2025-09-15 |
| Phase | NA |
What the finished NCT06335589 record still lists
NCT06335589 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 156-participant average among 66 other Stress Disorders, Post-Traumatic trials with a reported enrollment target (81% lower).
The record links to 1 condition, with Stress Disorders, Post-Traumatic appearing as the primary indexed condition, and to 2 interventions - of which EBP-Massed is the first listed.
NCT06335589 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT06335589 about?
NCT06335589 is a clinical study titled "Adapting Treatment Delivery to Improve Retention in Evidence-Based PTSD Treatment". Posttraumatic stress disorder (PTSD) is prevalent among Veterans and effective evidence-based psychotherapies (EBPs) for PTSD have been implemented within the Veterans Health Administration (VHA). However, retention in PTSD EBPs is poor. Premature dropout is associated with worse clinical outcomes a...
What is the current status of trial NCT06335589?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2024-06-24. Estimated completion is 2025-09-15.
What conditions does trial NCT06335589 study?
This clinical trial studies the following conditions: Stress Disorders, Post-Traumatic.
What interventions are being tested in trial NCT06335589?
The interventions under investigation include: EBP-Massed (OTHER), EBP-TAU (OTHER).
Who is sponsoring clinical trial NCT06335589?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06335589 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stress Disorders, Post-Traumatic
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06335589's enrollment target sits among peer trials
30 57th of 66 higher than 7 of 66 other Stress Disorders, Post-Traumatic trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stress Disorders, Post-Traumatic trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Manage Emotions to Reduce Aggression (MERA)
RECRUITING · NA
-
SMART Therapist Training: A Hybrid Factorial-SMART Design
RECRUITING · NA
-
Postpartum Care in the NICU (PeliCaN) Transitions
RECRUITING · NA
-
Healthy Recovery After Trauma Study
RECRUITING · NA
-
Intervention to Enhance Coping and Help-seeking Among Youth in Foster Care
RECRUITING · NA
-
Whole Health in VA Mental Health: Omnis Salutis
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI